Bazaar.UpdateπŸ“Š
14.3K subscribers
31.1K photos
67 videos
7 files
180 links
πŸ“° Get Daily Stock Market News

Note- The channel is for Educational purpose only!We are not responsible for your PROFITS or LOSES
Download Telegram
SURAT TRADE Q2 FY27 (STANDALONE) | OK 🌱

β€’ Net Profit: β‚Ή1.81 Cr | ↑ 572.99% YoY | ↓ 81.25% QoQ

β€’ Revenue: β‚Ή51.66 Cr | ↑ 209.90% YoY | ↑ 4.70% QoQ

β€’ EBITDA: β‚Ή1.33 Cr Loss | Loss narrowed YoY | Loss vs Profit QoQ

β€’ EBITDA Margin: -2.58% vs -9.90% YoY | 6.71% QoQ
IGARASHI MOTORS Q2 FY27 (STANDALONE) | OK 🌱

β€’ Net Profit: β‚Ή6 Cr | ↑ 41% YoY | ↓ 6% QoQ

β€’ Revenue: β‚Ή255 Cr | ↑ 17% YoY | ↑ 2% QoQ

β€’ Operating Profit: β‚Ή26 Cr | ↑ 13% YoY | ↑ 8% QoQ

β€’ Operating Margin: 10.4% vs 10.7% YoY | 9.8% QoQ

β€’ EPS: β‚Ή2.03 | ↑ 41% YoY | ↓ 6% QoQ

β€’ Other Income: Nil
❀1
OIL COUNTRY TUBULAR Q2 FY27 (STANDALONE) | GOOD βœ…

β€’ Net Loss: β‚Ή12 Cr | Loss narrowed 43% YoY | 18% QoQ

β€’ Revenue: β‚Ή25 Cr | ↑ 150% YoY | ↑ 44% QoQ

β€’ EBITDA: β‚Ή4 Cr Profit vs β‚Ή2 Cr Loss (YoY) | ↑ 245% QoQ

β€’ EBITDA Margin: 15.2% vs -23.0% YoY | 6.4% QoQ
BHARAT FORGE: H2 FY27 OUTLOOK CO SAYS MAINTAIN EXPECTATIONS OF REVENUE GROWTH OF 20-25% IN FY27 FOR THE INDIAN MANUFACTURING BUSINESS.
Strong Guidance from Shilpa Medi

CDMO orders from EU to contribute in H2

EU commercial supplies begin 2HFY27 for CDMO

Margins expansion due to better utilization

CDMO Biologic offerings to drive significant biosimilar revenue growth
❀1
πŸ“Š SJS ENTERPRISES Q2 FY27 – CONCALL HIGHLIGHTS

β€’ Raises FY27 EBITDA margin guidance to 29–30%.

β€’ Revises revenue growth guidance to 1.2–1.5x industry growth.

β€’ Targets export contribution of 14–15% by FY28.

β€’ Targets β‚Ή500–700 Cr display revenue by 2031.
BMW INDUSTRIES Q2 FY27

β€’ Net Profit: β‚Ή22 Cr | ↑ 44% YoY | ↑ 13% QoQ

β€’ Revenue: β‚Ή182 Cr | ↑ 25% YoY | ↑ 9% QoQ

β€’ Operating Profit: β‚Ή35 Cr | ↓ 6% YoY | ↑ 3% QoQ

β€’ Operating Margin: 19.2% vs 25.5% YoY | 20.3% QoQ

β€’ EPS: β‚Ή0.96 | ↑ 43% YoY | ↑ 13% QoQ

β€’ Other Income: β‚Ή14 Cr
IRB INFRASTRUCTURE Q2 FY27

β€’ Net Profit: β‚Ή260 Cr | ↑ 85% YoY | ↓ 15% QoQ

β€’ Revenue: β‚Ή1,897 Cr | ↑ 8% YoY | ↓ 11% QoQ

β€’ Operating Profit: β‚Ή1,055 Cr | ↑ 14% YoY | ↓ 8% QoQ

β€’ Operating Margin: 55.6% vs 52.8% YoY | 53.9% QoQ

β€’ EPS: β‚Ή0.22 | ↑ 83% YoY | ↓ 12% QoQ

β€’ Other Income: β‚Ή47 Cr
IPCALAB: Q2 CONS NET PROFIT 3.75B RUPEES VS 2.83B (YOY)

IPCALAB: Q2 EBITDA 6.73B RUPEES VS 5.45B (YOY); Q2 EBITDA MARGIN 23.14% VS 21.32% (YOY)

IPCALAB: Q2 REVENUE 29.1B RUPEES VS 25.57B (YOY)
❀2
NIFTY UP 600 PTS
πŸ”₯6🀩2❀1
BIRLACABLE: Q2 SL NET PROFIT 378M RUPEES VS 6.9M (YOY)

BIRLACABLE: Q2 EBITDA 547M RUPEES VS 66.5M (YOY); Q2 EBITDA MARGIN 15.42% VS 3.77% (YOY)

BIRLACABLE: Q2 REVENUE 3.55B RUPEES VS 1.76B (YOY)
❀2
YOGI: Q2 CONS NET PROFIT 4.2M RUPEES VS 92.9M (YOY)

YOGI: Q2 EBITDA LOSS 3.4M RUPEES VS PROFIT 127.2M (YOY)

YOGI: Q2 REVENUE 506.3M RUPEES VS 1.35B (YOY)
M&M: INDUSTRY OUTLOOK REDUCED TO FLATTISH IN F27; MONSOON DEFICIT WIDENED AND RESERVOIR LEVEL DETERIORATED BETWEEN JULY AND OCT
M&M: CO DOWNGRADES OUTLOOK FOR FY27 FOR TRACTOR FROM HIGH SINGLE DIGIT TO FLATTISH
CEIGALL INDIA Q2 FY27 βœ…

β€’ Net Profit: β‚Ή91 Cr | ↑57% YoY | ↑48% QoQ

β€’ Revenue: β‚Ή1,022 Cr | ↑27% YoY | ↑5% QoQ

β€’ EBITDA: β‚Ή174 Cr | ↑53% YoY | ↑21% QoQ

β€’ EBITDA Margin: 17.0% vs 14.1% YoY | 14.8% QoQ
POLY MEDICURE Q2 FY27 🌱

β€’ Net Profit: β‚Ή95 Cr | ↑4% YoY | ↑12% QoQ

β€’ Revenue: β‚Ή581 Cr | ↑31% YoY | ↑10% QoQ

β€’ EBITDA: β‚Ή138 Cr | ↑18% YoY | ↑10% QoQ

β€’ EBITDA Margin: 23.7% vs 26.3% YoY | 23.8% QoQ

β€’ EPS: β‚Ή9.38 vs β‚Ή9.06 (YoY) | β‚Ή8.49 (QoQ)

β€’ Other Income: β‚Ή19 Cr vs β‚Ή32 Cr (YoY) | β‚Ή33 Cr (QoQ)
PATEL ENGINEERING Q2 FY27 ⚠️

β€’ Net Profit: β‚Ή87 Cr | ↑19% YoY | ↓12% QoQ

β€’ Revenue: β‚Ή1,211 Cr | 0% YoY | ↓5% QoQ

β€’ EBITDA: β‚Ή150 Cr | ↓5% YoY | ↓16% QoQ

β€’ EBITDA Margin: 12.4% vs 13.1% YoY | 14.0% QoQ

β€’ EPS: β‚Ή0.86 vs β‚Ή0.82 (YoY) | β‚Ή0.98 (QoQ)

β€’ Other Income: β‚Ή48 Cr vs β‚Ή63 Cr (YoY) | β‚Ή25 Cr (QoQ)
JOJO Ltd – STANDALONE Q2 FY27 RESULTS

Financial results for the quarter and half-year ended September 30, 2026:

- Standalone Q2 revenue: INR 4.52 Cr (up 317.6% YoY)

- Standalone Q2 PAT: INR 0.46 Cr (up 608.3% YoY)

- Standalone H1 revenue: INR 8.67 Cr (up 255.5% YoY)

- Standalone H1 PAT: INR 1.55 Cr (up 495.7% YoY)

- Expanded distribution via Prime Video, JioFastTV, Samsung TV Plus, and Tata Play Binge
SANJIVANI PARENTERAL Q2 FY27 🌟

β€’ Net Profit: β‚Ή4 Cr | ↑153% YoY | ↑66% QoQ

β€’ Revenue: β‚Ή25 Cr | ↑63% YoY | ↑6% QoQ

β€’ EBITDA: β‚Ή6 Cr | ↑188% YoY | ↑55% QoQ

β€’ EBITDA Margin: 25.6% vs 14.5% YoY | 17.5% QoQ
JINDAL WORLDWIDE Q2 FY27 🌱

β€’ Net Profit: β‚Ή19 Cr | ↑56% YoY | ↓43% QoQ

β€’ Revenue: β‚Ή595 Cr | ↑4% YoY | ↑4% QoQ

β€’ EBITDA: β‚Ή34 Cr | ↑12% YoY | ↑14% QoQ

β€’ EBITDA Margin: 5.8% vs 5.3% YoY | 5.3% QoQ

β€’ EPS: β‚Ή0.19 vs β‚Ή0.12 (YoY) | β‚Ή0.32 (QoQ)

β€’ Other Income: β‚Ή0 Cr vs β‚Ή0 Cr (YoY) | β‚Ή18 Cr (QoQ)
❀1
BREAKING: Houthis demand $51 billion from Saudi Arabia to end conflict
❀1